ORHB logo

ORHub, Inc. (ORHB)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

ORHB steht fuer ORHub, Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Die Aktie erzielt 65/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 16. März 2026
65/100 KI-Bewertung

ORHub, Inc. (ORHB) Gesundheitswesen & Pipeline-Uebersicht

CEOChristopher Wiggins
HauptsitzPhoenix, US
IPO-Jahr2009

ORHub, Inc. provides a cloud-based surgical software solution for real-time data analytics, targeting hospitals and medical device vendors. The company's focus on capturing and analyzing surgical data aims to improve efficiency and outcomes in the healthcare sector, positioning it within the growing market for healthcare information services.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

ORHub, Inc. presents a speculative investment opportunity within the healthcare information services sector, driven by its focus on real-time surgical data analytics. The company's cloud-based software solution aims to improve surgical outcomes and efficiency for hospitals and medical device vendors. A key value driver is the potential for increased adoption of its software, leading to revenue growth. However, ORHub's negative profit margin of -4120.4% and small market capitalization of $0.00B indicate significant financial risks. The company's beta of -3.58 suggests a high level of volatility relative to the market. Successful execution of its growth strategies and achieving profitability are critical for realizing investment value. Investors should carefully consider the risks associated with investing in a small, unprofitable company in a competitive industry.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • ORHub, Inc. operates in the healthcare information services sector, providing surgical software and real-time data analytics.
  • The company's cloud-based software solution captures data before, during, and after surgery, aiming to improve surgical outcomes.
  • ORHub's gross margin stands at 68.6%, indicating a strong ability to generate revenue from its products and services.
  • The company's market capitalization is $0.00B, reflecting its small size and potential for high volatility.
  • ORHub's P/E ratio is -0.01, and its profit margin is -4120.4%, indicating that the company is currently unprofitable.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Cloud-based software solution
  • Focus on real-time surgical data analytics
  • Potential to improve surgical outcomes
  • Serves multiple stakeholders in the healthcare industry

Schwaechen

  • Negative profit margin
  • Small market capitalization
  • High beta indicating volatility
  • Dependence on adoption by hospitals and vendors

Katalysatoren

  • Ongoing: Expansion into new surgical specialties, increasing the addressable market.
  • Ongoing: Strategic partnerships with medical device vendors, leading to integrated solutions.
  • Upcoming: Development of AI-powered analytics capabilities, enhancing the software solution within 2-3 years.
  • Ongoing: Geographic expansion into international markets, diversifying revenue streams within 3-5 years.
  • Ongoing: Focus on data security and compliance, building trust with customers.

Risiken

  • Potential: Competition from established healthcare IT providers, impacting market share.
  • Potential: Regulatory changes and compliance requirements, increasing operational costs.
  • Ongoing: Data security and privacy concerns, leading to potential breaches and liabilities.
  • Ongoing: Slow adoption of new technologies by healthcare providers, delaying revenue growth.
  • Ongoing: Negative profit margin and small market capitalization, indicating financial instability.

Wachstumschancen

  • Expansion into New Surgical Specialties: ORHub, Inc. has the opportunity to expand its software solution to cater to a broader range of surgical specialties beyond its current focus. This expansion could involve tailoring the software to specific procedures and workflows within specialties such as orthopedic surgery, cardiovascular surgery, and neurosurgery. The market for surgical software is estimated to grow as hospitals seek to improve efficiency and outcomes across all surgical areas. By targeting new specialties, ORHub can increase its addressable market and drive revenue growth. The timeline for this expansion could be within the next 2-3 years, contingent on product development and market research.
  • Strategic Partnerships with Medical Device Vendors: ORHub, Inc. can pursue strategic partnerships with medical device vendors to integrate its software solution with their devices and platforms. This integration would provide seamless data capture and analysis during surgical procedures, enhancing the value proposition for both ORHub and its partners. The market for medical devices is substantial, and vendors are increasingly seeking to offer integrated solutions that combine devices with data analytics capabilities. These partnerships could lead to increased adoption of ORHub's software and generate new revenue streams. The timeline for establishing these partnerships could be within the next 1-2 years, depending on negotiations and integration efforts.
  • Geographic Expansion into International Markets: ORHub, Inc. has the potential to expand its operations into international markets, particularly in regions with growing healthcare spending and increasing adoption of digital health technologies. This expansion could involve establishing partnerships with local distributors and healthcare providers to market and sell its software solution. The global market for healthcare information services is expanding, and international markets offer significant growth opportunities. By entering new geographic regions, ORHub can diversify its revenue streams and reduce its reliance on the domestic market. The timeline for international expansion could be within the next 3-5 years, contingent on market research and regulatory approvals.
  • Development of AI-Powered Analytics Capabilities: ORHub, Inc. can invest in developing artificial intelligence (AI)-powered analytics capabilities to enhance its software solution. This could involve incorporating machine learning algorithms to identify patterns and predict outcomes in surgical procedures. The market for AI in healthcare is growing rapidly, and AI-powered analytics can provide valuable insights for surgeons and hospitals. By adding AI capabilities, ORHub can differentiate its software and attract new customers. The timeline for developing and implementing AI-powered analytics could be within the next 2-3 years, depending on research and development efforts.
  • Focus on Data Security and Compliance: ORHub, Inc. can strengthen its focus on data security and compliance with healthcare regulations, such as HIPAA. This would involve implementing robust security measures to protect patient data and ensuring compliance with all applicable regulations. Data security and compliance are critical concerns in the healthcare industry, and hospitals are increasingly seeking vendors with strong security practices. By prioritizing data security and compliance, ORHub can build trust with its customers and gain a competitive advantage. The timeline for strengthening data security and compliance is ongoing, as it requires continuous monitoring and improvement.

Chancen

  • Expansion into new surgical specialties
  • Strategic partnerships with medical device vendors
  • Geographic expansion into international markets
  • Development of AI-powered analytics capabilities

Risiken

  • Competition from established healthcare IT providers
  • Regulatory changes and compliance requirements
  • Data security and privacy concerns
  • Slow adoption of new technologies by healthcare providers

Wettbewerbsvorteile

  • Proprietary cloud-based software solution.
  • Focus on real-time surgical data analytics.
  • Relationships with hospitals and medical device vendors.

Ueber ORHB

ORHub, Inc., based in Phoenix, Arizona, is a healthcare information services company specializing in surgical software and real-time surgical data analytics. The company was founded with the vision of transforming surgical processes through data-driven insights. Its core offering is a cloud-based software solution designed to capture comprehensive data before, during, and after surgical procedures. This data is then analyzed to provide actionable insights for various stakeholders in the healthcare ecosystem. ORHub's software applications enable hospitals and medical device vendors to utilize web-enabled devices to create anatomical graphic depictions during surgery, enhancing precision and decision-making. The company's suite of products is tailored to meet the needs of hospitals, patients, government entities, and medical device vendors, aiming to improve surgical outcomes, streamline processes, and reduce costs. ORHub's focus on real-time data analytics differentiates it within the competitive healthcare information services market, offering a specialized solution for surgical environments.

Was das Unternehmen tut

  • Provides a cloud-based software solution for capturing surgical data.
  • Offers real-time surgical data analytics to healthcare providers.
  • Serves hospitals, patients, government entities, and medical device vendors.
  • Enables web-enabled devices to create anatomical graphic depictions during surgery.
  • Aims to improve surgical outcomes and streamline processes.
  • Offers tools for enhanced surgical data management and analysis.

Geschaeftsmodell

  • Provides a cloud-based software solution on a subscription basis.
  • Generates revenue from hospitals and medical device vendors.
  • Offers data analytics services to healthcare providers.

Branchenkontext

ORHub, Inc. operates within the healthcare information services industry, a sector experiencing growth due to the increasing adoption of digital health technologies and the demand for data-driven insights. The market includes companies offering electronic health records, telehealth solutions, and data analytics platforms. ORHub's focus on surgical data analytics positions it within a niche segment of this market. Competitors include companies like FDBH, HLTT, ICCT, OLMM, and OZYMF, which offer various healthcare IT solutions. The industry is characterized by regulatory compliance requirements and the need for interoperability among different systems. ORHub's success depends on its ability to differentiate its offerings and capture market share in this competitive landscape.

Wichtige Kunden

  • Hospitals and surgical centers
  • Medical device vendors
  • Healthcare providers
KI-Zuversicht: 69% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

ORHub, Inc. (ORHB) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ORHB.

Kursziele

Wall-Street-Kurszielanalyse fuer ORHB.

MoonshotScore

65/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ORHB auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Christopher Wiggins

CEO

Christopher Wiggins serves as the CEO of ORHub, Inc. His background includes experience in executive leadership and strategic management within the technology and healthcare sectors. He has a track record of driving growth and innovation in organizations. Prior to joining ORHub, Wiggins held leadership positions in various companies, where he focused on developing and implementing strategies to improve operational efficiency and market competitiveness. His expertise spans areas such as product development, sales and marketing, and financial management.

Erfolgsbilanz: Since assuming the role of CEO at ORHub, Christopher Wiggins has focused on expanding the company's market reach and enhancing its product offerings. Key milestones under his leadership include securing partnerships with hospitals and medical device vendors, as well as driving the development of new features for the company's software solution. He has also worked to strengthen the company's financial position and improve its operational efficiency.

ORHB OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that ORHub, Inc. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and greater price volatility.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity on the OTC market can be highly variable. ORHub, Inc.'s trading volume and bid-ask spread should be carefully assessed to determine the ease of buying or selling shares. Low trading volume and wide bid-ask spreads can make it difficult to execute trades at desired prices and may increase transaction costs. Investors should be aware of the potential for illiquidity and price manipulation in the OTC market.
OTC-Risikofaktoren:
  • Limited financial disclosure
  • Potential for illiquidity
  • Greater price volatility
  • Higher risk of fraud or manipulation
  • Lack of regulatory oversight
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's OTC Markets profile for disclosures and compliance information.
  • Check for any regulatory actions or legal proceedings involving the company.
  • Evaluate the company's liquidity and trading volume.
  • Consult with a financial advisor before investing.
Legitimitaetssignale:
  • Company has an operating business with customers.
  • CEO with prior experience.
  • Company has a website and investor relations presence.
  • Company has patents or intellectual property.
  • Company has a board of directors.

Was Anleger ueber ORHub, Inc. (ORHB) wissen wollen

What are the key factors to evaluate for ORHB?

ORHub, Inc. (ORHB) currently holds an AI score of 65/100, indicating moderate score. Key strength: Cloud-based software solution. Primary risk to monitor: Potential: Competition from established healthcare IT providers, impacting market share.. This is not financial advice.

How frequently does ORHB data refresh on this page?

ORHB prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ORHB's recent stock price performance?

Recent price movement in ORHub, Inc. (ORHB) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Cloud-based software solution. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ORHB overvalued or undervalued right now?

Determining whether ORHub, Inc. (ORHB) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ORHB?

Before investing in ORHub, Inc. (ORHB), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ORHB to a portfolio?

Potential reasons to consider ORHub, Inc. (ORHB) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Cloud-based software solution. Additionally: Focus on real-time surgical data analytics. The AI-driven MoonshotScore of 65/100 reflects solid quantitative fundamentals. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ORHB?

Yes, most major brokerages offer fractional shares of ORHub, Inc. (ORHB) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ORHB's earnings and financial reports?

ORHub, Inc. (ORHB) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ORHB earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data and may be subject to change.
  • AI analysis is pending for ORHB, which may provide additional insights.
  • OTC market investments carry higher risks than exchange-listed stocks.
Datenquellen

Popular Stocks